Human astrocytes express 14-3-3 sigma in response to oxidative and DNA-damaging stresses

Neuroscience Research

Volumn 56, Issue 1, 2006, Pages 61-72

  Satoh, Jun ichi ^a,b   Tabunoki, Hiroko ^a   Nanri, Yusuke ^b   Arima, Kunimasa ^c   Yamamura, Takashi ^b  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c National Center of Neurology and Psychiatry   (Japan)

Author keywords

14 3 3 Sigma; Astrocytes; DNA damage; Multinucleated morphology; Multiple sclerosis; p53

Indexed keywords

4 HYDROXYNONENAL; 5 AZA 2' DEOXYCYTIDINE; 8 HYDROXYDEOXYGUANOSINE; ETOPOSIDE; GYRASE INHIBITOR; HYDROGEN PEROXIDE; PROTEIN 14 3 3; PROTEIN P21; PROTEIN P53;

ARTICLE; ASTROCYTE; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; DEMYELINATION; DNA DAMAGE; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; MITOSIS; MULTINUCLEAR CELL; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; UPREGULATION; WESTERN BLOTTING;

14-3-3 PROTEINS; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ASTROCYTES; BIOLOGICAL MARKERS; BRAIN; BRAIN ISCHEMIA; CELLS, CULTURED; CEREBRAL INFARCTION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; EXONUCLEASES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; PROTEIN ISOFORMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33748779542     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.05.007     Document Type: Article

References (46)

1. Berg D., Holzmann C., and Riess O. 14-3-3 proteins in the nervous system. Nat. Rev. Neurosci. 4 (2002) 752-762
2. Bhatia K., Siraj A.K., Hussain A., Bu R., and Gutiérrez M.I. The tumor suppressor gene 14-3-3 σ is commonly methylated in normal and malignant lymphoid cells. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 165-169
3. Bond J., Roberts E., Mochida G.H., Hampshire D.J., Scott S., Askham J.M., Springell K., Mahadevan M., Crow Y.J., Markham A.F., Walsh C.A., and Woods C.G. ASPM is a major determinant of cerebral cortical size. Nat. Genet. 32 (2002) 316-320
4. Bootcov M.R., Bauskin A.R., Valenzuela S.M., Moore A.G., Bansal M., He X.Y., Zhang H.P., Donnellan M., Mahler S., Pryor K., Walsh B.J., Nicholson R.C., Fairlie W.D., Por S.B., Robbins J.M., and Breit S.N. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 11514-11519
5. Cahill D.P., Lengauer C., Yu J., Riggins G.J., Willson J.K., Markowitz S.D., Kinzler K.W., and Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature 392 (1998) 300-303
6. Carpenter M.K., Cui X., Hu Z.-Y., Jackson J., Sherman S., Seiger A., and Wahlberg L.U. In vitro expansion of a multipotent population of human neural progenitor cells. Exp. Neurol. 158 (1999) 262-278
7. Chan T.A., Hermeking H., Lengauer C., Kinzler K.W., and Vogelstein B. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature 401 (1999) 616-620
8. Chen H.-K., Fernandez-Funez P., Acevedo S.F., Lam Y.C., Kaytor M.D., Fernandez M.H., Aitken A., Skoulakis E.M., Orr H.T., Botas J., and Zoghbi H.Y. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113 (2003) 457-468
9. Dellambra E., Golisano O., Bondanza S., Siviero E., Lacal P., Molinari M., D'Atri S., and De Luca M. Downregulation of 14-3-3σ prevents clonal evolution and leads to immortalization of primary human keratinocytes. J. Cell Biol. 149 (2000) 1117-1129
10. Ferguson A.T., Evron E., Umbricht C.B., Pandita T.K., Chan T.A., Hermeking H., Marks J.R., Lambers A.R., Fytreal P.A., Stampfer M.R., and Sukumar S. High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 6049-6054
11. Fu H., Subramanian R.R., and Masters S.C. 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 617-647
12. Hermeking H., Lengauer C., Polyak K., He T.-C., Zhang L., Thiagalingam S., Kinzler K.W., and Vogelstein B. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1 (1997) 3-11
13. Hoh J., Jin S., Parrado T., Edington J., Levine A.J., and Ott J. The p53MH algorithm and its application in detecting p53-responsive genes. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 8467-8472
14. Jenson S.D., Robetorye R.S., Bohling S.D., Schumacher J.A., Morgan J.W., Lim M.S., and Elenitoba-Johnson K.S. Validation of cDNA microarray gene expression data obtained from linearly amplified RNA. J. Clin. Pathol. Mol. Pathol. 56 (2003) 307-312
15. Kaneuchi M., Sasaki M., Tanaka Y., Shiina H., Verma M., Ebina Y., Nomura E., Yamamoto R., Sakuragi N., and Dahiya R. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer. Biochem. Biophys. Res. Commun. 316 (2004) 1156-1162
16. Leffers H., Madsen P., Rasmussen H.H., Honoré B., Andersen A.H., Walbum E., Vandekerckhove J., and Celis J.E. Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signaling pathway. J. Mol. Biol. 231 (1993) 982-998
17. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., and Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396 (1998) 580-584
18. Li P.-X., Wong J., Ayed A., Ngo D., Brade A.M., Arrowsmith C., Austin R.C., and Klamut H.J. Placental transforming growth factor-β is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J. Biol. Chem. 275 (2000) 20127-20135
19. Lu F., Selak M., O'Connor J., Croul S., Lorenzana C., Butunoi C., and Kalman B. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J. Neurol. Sci. 177 (2000) 95-103
20. MacKintosh C. Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem. J. 381 (2004) 329-342
21. Martin-Lluesma S., Stucke V.M., and Nigg E.A. Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment of Mad1/Mad2. Science 297 (2002) 2267-2270
22. Meek D.W. The p53 response to DNA damage. DNA Repair 3 (2004) 1049-1056
23. Mirza A., McGuirk M., Hockenberry T.N., Wu Q., Ashar H., Black S., Wen S.F., Wang L., Kirschmeier P., Bishop W.R., Nielsen L.L., Pickett C.B., and Liu S. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21 (2002) 2613-2622
24. Mirza A., Wu Q., Wang L., McClanahan T., Bishop W.R., Gheyas F., Ding W., Hutchins B., Hockenberry T., Kirschmeier P., Greene J.R., and Liu S. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression. Oncogene 22 (2003) 3645-3654
25. Nakajima T., Shimooka H., Weixa P., Segawa A., Motegi A., Jian Z., Masuda N., Ide M., Sano T., Oyama T., Tsukagoshi H., Hamanaka K., and Maeda M. Immunohistochemical demonstration of 14-3-3 sigma protein in normal human tissues and lung cancers, and the preponderance of its strong expression in epithelial cells of squamous cell lineage. Pathol. Int. 53 (2003) 353-360
26. Newcombe J., Li H., and Cuzner M.L. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis. Neuropathol. Appl. Neurobiol. 20 (1994) 152-162
27. Nishie M., Mori F., Ogawa M., Sannohe S., Tanno K., Kurahashi K., Kuroda N., and Wakabayashi K. Multinucleated astrocytes in old demyelinated plaques in a patient with multiple sclerosis. Neuropathology 24 (2004) 248-253
28. Satoh J., Yamamura T., and Arima K. The 14-3-3 protein ε isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes. Am. J. Pathol. 165 (2004) 577-592
29. Satoh J., Nakanishi M., Koike F., Miyake S., Yamamoto T., Kawai M., Kikuchi S., Nomura K., Yokoyama K., Ota K., Kanda T., Fukazawa T., and Yamamura T. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol. Dis. 18 (2005) 537-550
30. Schlote W. Piloid astrocytes (spongiocytes) and Rosenthal fibers in multiple sclerosis. Acta Neuropathol. 33 (1975) 35-44
31. Schober A., Böttner M., Strelau J., Kinscherf R., Bonaterra G.A., Barth M., Schilling L., Fairlie W.D., Breit S.N., and Unsicker K. Expression of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. J. Comp. Neurol. 439 (2001) 32-45
32. Slee E.A., O'Connor D.J., and Lu X. To die or not to die: how does p53 decide?. Oncogene 23 (2004) 2809-2818
33. Smith K.J., Kapoor R., and Felts P.A. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol. 9 (1999) 62-92
34. Strelau J., Sullivan A., Böttner M., Lingor P., Falkenstein E., Syter-Crazzolara C., Galter D., Jaszai J., Krieglstein K., and Unsicker K. Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J. Neurosci. 20 (2000) 8597-8603
35. Toyokuni S., Miyake N., Hiai H., Hagiwara M., Kawakishi S., Osawa T., and Uchida K. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett. 359 (1995) 189-191
36. Toyokuni S., Tanaka T., Hattori Y., Nishiyama Y., Yoshida A., Uchida K., Jiai H., Ochi H., and Osawa T. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab. Invest. 76 (1997) 365-374
37. Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., and Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-Hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J. Biol. Chem. 274 (1999) 2234-2242
38. Umahara T., Uchihara T., Tsuchiya K., Nakamura A., Ikeda K., Iwamoto T., and Takasaki M. Immunolocalization of 14-3-3 isoforms in brains with Pick body disease. Neurosci. Lett. 371 (2004) 215-219
39. Urano T., Saito T., Tsukui T., Fujita M., Hosoi T., Muramatsu M., Ouchi Y., and Inoue S. Efp targets 14-3-3σ for proteolysis and promotes breast tumor growth. Nature 417 (2002) 871-875
40. Urano T., Takahashi S., Suzuki T., Fujimura T., Fujita M., Kumagai J., Horie-Inoue K., Sasano H., Kitamura T., Ouchi Y., and Inoue S. 14-3-3σ is down-regulated in human prostate cancer. Biochem. Biophys. Res. Commun. 319 (2004) 795-800
41. Vladimirova O., O'Connor J., Cahil A., Alder H., Butunoi C., and Kalman B. Oxidative damage to DNA in plaques of MS brains. Mult. Scler. 4 (1998) 413-418
42. Wang Y., Barbacioru C., Hyland F., Xiao W., Hunkapiller K.L., Blake J., Chan F., Gonzalez C., Zhang L., and Samaha R.R. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. BMC Genomics 7 (2006) 59 (online)
43. Yang H.-Y., Wen Y.-Y., Chen C.-H., Lozano G., and Lee M.-H. 14-3-3σ positively regulates p53 and suppresses tumor growth. Mol. Cell Biol. 23 (2003) 7096-7107
44. Zerr I., Bodemer M., Gefeller O., Otto M., Poser S., Wiltfang J., Windl O., Kretzschmar H.A., and Weber T. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann. Neurol. 43 (1998) 32-40
45. Zhao R., Gish K., Murphy M., Yin Y., Notterman D., Hoffman W.H., Tom E., Mack D.H., and Levine A.J. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 14 (2000) 981-993
46. Zhou B.-B.S., and Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 408 (2000) 433-439